Akari Therapeutics Plc (AKTX)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 27, 2026 | CORRESP | Neutral/Informational | Moderate | Akari Therapeutics, Plc has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking for the statement to beco… | Read Filing EDGAR |
| Jan. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated January 27, 2026, informs Akari Therapeutics that their registration statement on Form S-1, filed on January 23, 2026, will not be reviewed by the SEC… | Read Filing EDGAR |
| Dec. 1, 2025 | CORRESP | Neutral/Informational | Moderate | Akari Therapeutics, Plc has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1, originally filed on November 17, 2025. The… | Read Filing EDGAR |
| Jul. 30, 2025 | CORRESP | Neutral/Informational | Moderate | Akari Therapeutics PLC has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3. They are seeking to have the state… | Read Filing EDGAR |
| Jul. 30, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Akari Therapeutics that they will not review the company's registration statement filed on July 29, 2025. This indicates that the SEC is not taking an … | Read Filing EDGAR |